A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Immunogenicity and Safety of a Two Vaccination Regimen With an LT Vaccine Patch in Healthy Adults.

Trial Profile

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Immunogenicity and Safety of a Two Vaccination Regimen With an LT Vaccine Patch in Healthy Adults.

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Jun 2014

At a glance

  • Drugs Escherichia coli vaccine (Primary)
  • Indications Enterotoxigenic Escherichia coli infections; Traveller's diarrhoea
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Intercell USA
  • Most Recent Events

    • 18 Apr 2014 Primary endpoints and drug dosage have been added as reported by ClinicalTrials.gov record.
    • 12 Aug 2010 Actual end date (November 2009) added as reported by ClinicalTrials.gov.
    • 12 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top